Profile data is unavailable for this security.
About the company
Simcere Pharmaceutical Group Ltd is a company engaged in research and development, production and sales of drugs. The Company's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The Company also produces various drugs, including Endostar used for oncology. The Company is also involved in providing promotion services for third-party drugs sold by medical institutions. The Company mainly conducts its businesses in the domestic market and overseas markets.
- Revenue in HKD (TTM)8.04bn
- Net income in HKD995.72m
- Incorporated2015
- Employees6.82k
- LocationSimcere Pharmaceutical Group LtdNo. 699-18, Xuanwu Road, Xuanwu DistrictNANJING ChinaCHN
- Websitehttps://www.simcere.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HUTCHMED (China) Ltd | 4.71bn | 3.65bn | 20.31bn | 1.78k | 5.57 | 2.11 | 5.42 | 4.32 | 4.18 | 4.18 | 5.39 | 11.01 | 0.3966 | 7.09 | 3.86 | 2,598,625.00 | 30.79 | -9.55 | 40.72 | -13.77 | 44.15 | 39.84 | 77.64 | -20.32 | 4.51 | -- | 0.07 | -- | -24.80 | 25.20 | -62.56 | -- | 15.93 | -- |
| Ab&B Bio Tech Co Ltd JS | 366.26m | -253.89m | 22.39bn | 583.00 | -- | 587.93 | -- | 61.12 | -0.6453 | -0.6453 | 0.9309 | 0.0968 | -- | -- | -- | -- | -- | -- | -- | -- | 67.29 | -- | -69.32 | -- | 0.3162 | -9.49 | 0.9646 | -- | 397.65 | -- | 39.09 | -- | -- | -- |
| Shanghai Henlius Biotech Inc | 6.56bn | 932.51m | 24.40bn | 3.54k | 41.09 | 9.94 | 17.29 | 3.72 | 1.72 | 1.72 | 12.07 | 7.09 | 0.5386 | 1.73 | 5.86 | 1,866,014.00 | 7.66 | -3.21 | 13.85 | -5.76 | 75.77 | 72.50 | 14.22 | -7.87 | 0.5046 | 10.47 | 0.5185 | -- | 6.11 | 128.98 | 50.26 | -- | 10.83 | -- |
| The United Laboratories Intl. Hldgs Ltd. | 15.95bn | 3.46bn | 24.84bn | 17.40k | 6.60 | 1.30 | 5.96 | 1.56 | 1.91 | 1.91 | 8.78 | 9.69 | 0.5397 | 2.89 | 5.97 | 938,419.90 | 11.71 | 9.37 | 17.46 | 14.54 | 47.24 | 44.33 | 21.70 | 15.06 | 1.60 | -- | 0.2472 | 26.01 | 0.1387 | 10.39 | -1.54 | 32.89 | 37.25 | 45.96 |
| Sunshine Lake Pharma Co Ltd | 3.82bn | -447.93m | 25.20bn | 6.53k | -- | 56.99 | 21,090.14 | 6.60 | -0.7768 | -0.7768 | 6.62 | 0.7674 | -- | -- | -- | 582,850.30 | -- | -- | -- | -- | 73.62 | -- | -12.86 | -- | 0.7739 | -0.7591 | 0.5111 | -- | -37.06 | -- | -212.17 | -- | -- | -- |
| PegBio Co Ltd | -100.00bn | -100.00bn | 26.05bn | 58.00 | -- | 89.02 | -- | -- | -- | -- | -- | 0.7481 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.07 | -- | 0.2439 | -- | -- | -- | -1.49 | -- | -- | -- |
| Grand Pharmaceutical Group Ltd | 11.70bn | 2.08bn | 26.80bn | 12.44k | 12.70 | 1.54 | 10.34 | 2.29 | 0.5943 | 0.5943 | 3.35 | 4.90 | 0.4557 | 3.66 | 3.88 | 976,472.80 | 7.99 | 10.40 | 10.81 | 14.24 | 57.64 | 61.04 | 17.53 | 22.80 | 0.9872 | -- | 0.2107 | 29.12 | 10.59 | 12.06 | 31.30 | 16.49 | 0.7398 | 22.05 |
| China Resources Pharmaceutical Group Ltd | 295.20bn | 3.19bn | 28.84bn | 86.00k | 9.03 | 0.5101 | 2.21 | 0.0977 | 0.5084 | 0.5084 | 46.99 | 9.00 | 0.9434 | 5.57 | 2.41 | 4,060,518.00 | 2.86 | 3.14 | 10.28 | 11.78 | 15.81 | 15.59 | 3.03 | 3.02 | 1.12 | 11.26 | 0.4248 | 22.38 | 5.30 | 7.41 | -13.06 | 2.95 | 12.42 | 7.30 |
| Duality Biotherapeutics Inc | 2.46bn | -3.20bn | 30.92bn | 191.00 | -- | 9.16 | -- | 12.59 | -36.95 | -36.95 | 28.68 | 37.43 | -- | -- | -- | 14,442,920.00 | -- | -- | -- | -- | 37.13 | -- | -130.43 | -- | -- | -- | 0.0228 | -- | 8.66 | -- | -193.82 | -- | -- | -- |
| Simcere Pharmaceutical Group Ltd | 8.04bn | 995.72m | 32.71bn | 6.82k | 31.13 | 3.81 | 23.46 | 4.07 | 0.4048 | 0.4048 | 3.26 | 3.31 | 0.5845 | 2.20 | 2.81 | 1,221,077.00 | 7.24 | 8.74 | 9.93 | 12.42 | 81.00 | 78.53 | 12.39 | 15.60 | 1.57 | 4.72 | 0.1453 | 44.12 | 0.4148 | 5.67 | 2.57 | -6.09 | 8.48 | -- |
| Xuanzhu Biopharmaceutical Co Ltd | 36.15m | -629.40m | 33.07bn | 197.00 | -- | 34.56 | -- | 914.74 | -1.22 | -1.22 | 0.0698 | 1.85 | -- | -- | -- | -- | -- | -- | -- | -- | 41.02 | -- | -1,740.97 | -- | 1.10 | -- | 0.0013 | -- | 103,672.40 | -- | -85.13 | -- | -- | -- |
| China Medical System Holdings Ltd | 8.89bn | 1.87bn | 37.40bn | 6.10k | 19.85 | 1.94 | 17.33 | 4.21 | 0.7723 | 0.7723 | 3.68 | 7.89 | 0.4239 | 3.14 | 6.12 | 1,447,935.00 | 8.85 | 16.35 | 9.88 | 18.70 | 71.47 | 75.03 | 20.88 | 32.20 | 5.28 | -- | 0.0417 | 40.16 | -6.79 | 4.22 | -32.54 | -3.75 | 6.01 | -2.60 |
Data as of Feb 16 2026. Currency figures normalised to Simcere Pharmaceutical Group Ltd's reporting currency: Hong Kong Dollar HKD
6.18%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Feb 2026 | 32.61m | 1.26% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 25.14m | 0.97% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 22.90m | 0.88% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 22.27m | 0.86% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 13.91m | 0.54% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 12.56m | 0.48% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 8.79m | 0.34% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 7.82m | 0.30% |
| Goldman Sachs Asset Management LPas of 12 Feb 2026 | 7.36m | 0.28% |
| China Asset Management Co., Ltd.as of 28 Nov 2025 | 7.17m | 0.28% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
